Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Arthritis, Juvenile × Etanercept × Clear all

Phase

Phase 3 1 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Psoriasis 3 Lymphoma, Follicular 3 Uveitis 1 Pruritus 1 Pneumonia 1 Plaque, Amyloid 1 Cachexia 1 Bronchiolitis Obliterans Syndrome 1 Arthritis, Rheumatoid 1 Arthritis, Juvenile 1 Anorexia 1

Interventions

canakinumab 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Etanercept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00012506 2005-06-24

The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis

National Eye Institute (NEI)

Phase 3 Unknown

Arthritis, Juvenile, Uveitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡